Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia. - Wikidata - wikimedia - TriplyDB

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia.

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q38063197

about

Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy An analysis of the therapeutic benefits of genotyping in pediatric hematopoietic stem cell transplantation.Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations.Blocking autophagy enhanced leukemia cell death induced by recombinant human arginase.Association Between Combined Presence of Hepatitis C Virus and Polymorphisms in Different Genes With Toxicities of Methotrexate and 6-Mercaptopurine in Children With Acute Lymphoblastic Leukemia.A single day of 5-azacytidine exposure during development induces neurodegeneration in neonatal mice and neurobehavioral deficits in adult mice.Functional polymorphisms of xenobiotics metabolizing enzymes-a research topic.Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol.Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia.

P2860

Q28083449-13A0E06B-F23F-415C-8E02-C6B8DAD3A415 Q38372455-A3466C18-58CC-4B72-89E5-85E4C1C15C57 Q38688039-C9E2F87C-F9BE-4527-BB4D-5C4066FAB083 Q38813861-4AEFD921-1C6C-4752-A825-DA9E74B2E716 Q38855568-DD78E3FE-905C-4952-A09B-F32A011D69B1 Q39423542-E8EEB831-8D55-4EC8-8169-B9CC6399278D Q40492924-8136AD21-1FF3-4457-8FD6-20C4112F2240 Q41068390-4216166F-5233-4B27-A146-118297A9CC9E Q42706096-DC792056-4518-4A8C-8DC8-AA347153CC99 Q53653257-BE20F968-D6F8-41E1-A78A-D8AAF9242209

P2860

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q38063197

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Impact of genetic polymorphism ...... acute lymphoblastic leukemia.

@en

type

label

Impact of genetic polymorphism ...... acute lymphoblastic leukemia.

@en

prefLabel

Impact of genetic polymorphism ...... acute lymphoblastic leukemia.

@en

P1433

Q38063197-92CFD3D2-E0E9-4A5E-84B3-76DC1810E821

P1476

Q38063197-AC240342-B282-4AD3-868A-3F880E54AC1B

P2093

Q38063197-11F3913A-B889-49F5-9F54-F95AC90764ED

Q38063197-27D219AF-E65B-4372-B0EF-4A298494949A

P2860

Q38063197-01A56289-CDB7-497B-9E85-553D51C83B54

Q38063197-04610B9B-CCDD-4A84-BD93-272D37E96ECC

Q38063197-04CF22FF-878D-4C91-BFF8-13F7CF4E277B

Q38063197-0659EABA-5E48-4DF6-98FE-47FE1522E643

Q38063197-0B37F622-BF7D-4EAE-B2C8-5BAB0A440A97

Q38063197-15B8DFC4-6DCB-4029-A505-D6AB43057731

Q38063197-19F2A301-FD4D-4A91-865A-F6A00AA7C7A7

Q38063197-1D9208D8-45D5-4F15-9169-7B68860A6B3D

Q38063197-25743B47-1694-4A65-ACAA-220123024AE7

Q38063197-27D8D30E-C3B5-453D-9F0A-254C895D3C1F

P304

Q38063197-EBD9003F-872D-446E-8869-D4D01AF6A1B5

P31

Q38063197-506B8525-CD29-4B44-83EA-BDF584AADDC2

P356

Q38063197-0DEAC3E6-DEF6-4F1F-8A96-7E1F1132CE26

P478

Q38063197-A3BE8A13-08B2-4FF5-BC4E-22CC87C78155

P577

Q38063197-841CDAEE-924B-44EC-8F58-EDF7DA1C3DBD

P5875

Q38063197-50427921-CB7A-44D1-A3CE-D9112B710142

P698

Q38063197-EEF38B76-7ECA-4173-9648-756D71939E3B

P921

Q38063197-67FCF578-8693-4A21-962B-2B13AB6B675A

P932

Q38063197-72F2F088-1731-4629-98D1-8C70455BB8B3

P356

FGENE.2012.00249

P1433

Frontiers in Genetics

P1476

Impact of genetic polymorphism ...... acute lymphoblastic leukemia.

@en

P2093

Guillermo Gervasini

http://www.w3.org/2001/XMLSchema#string

Jose M Vagace

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing

A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinity

Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients

The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease

Cyclophosphamide cystitis--identification of acrolein as the causative agent

The cardiotoxicity of adriamycin and daunomycin in children

The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance

A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.

Selective metabolism of vincristine in vitro by CYP3A5.

Frequently relapsing thrombotic thrombocytopenic purpura treated with cytotoxic immunosuppressive therapy.

P304

249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FGENE.2012.00249

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233789784

http://www.w3.org/2001/XMLSchema#string

P698

23189085

http://www.w3.org/2001/XMLSchema#string

P921

P932

3504364

http://www.w3.org/2001/XMLSchema#string